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Time from Illness 
Onset to Death, 
1918 Inﬂ  uenza and 
Pneumococcal 
Pneumonia 
To the Editor: Brundage and 
Shanks (1) have studied time to death 
from the onset of inﬂ  uenza symptoms 
during the 1918 pandemic in military 
and civilian populations and found a 
median time to death of 7–11 days. 
They argue that these data support the 
idea that the deaths may be predomi-
nantly due to bacterial superinfection 
after the acute phase of inﬂ  uenza. We 
observed a similar 10-day median time 
to death among soldiers dying of inﬂ  u-
enza in 1918 (2), a ﬁ  nding consistent 
with the time to death for a bacterial 
superinfection, speciﬁ  cally  pneumo-
coccal bacteremic pneumonia (3).
The major bacterial pathogen 
associated with inﬂ  uenza-related 
pneumonia in 1918 was Streptococ-
cus pneumoniae ( 1,3). Neither anti-
microbial drugs nor serum therapy 
was available for treatment in 1918. 
To further analyze the time course of 
death from inﬂ  uenza in relation to that 
of pneumococcal pneumonia in 1918, 
we examined data collected by Tilgh-
man and Finland (4) from the pre–
antimicrobial drug era of the 1920s 
and 1930s. The Figure shows the dis-
tribution of time from onset of illness 
to death due to inﬂ  uenza-related pneu-
monia in 1918 compared with time to 
death due to untreated pneumococcal 
pneumonia in the 1920s and 1930s. 
The Figure indicates a close concor-
dance of the times to death. Similar 
times to death do not prove the speciﬁ  c 
bacterial etiology of the 1918 deaths. 
However, pneumococcal bacteremia 
was associated with most of the pneu-
monia deaths reported by Tilghman 
and Finland (4), and most 1918 inﬂ  u-
enza-related deaths were due to bac-
terial pneumonia (5). Also, up to 50% 
of patients dying from pneumonia in 
1918 had pneumococcal bacteremia 
(3). These similar times to death pro-
vide additional evidence that the inﬂ  u-
enza-related pneumonia deaths during 
the 1918 inﬂ   uenza pandemic were 
largely due to the pneumococcus. 
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Figure. Distribution of days of illness before death from inﬂ  uenza-related pneumonia, 1918, 
and from untreated pneumococcal pneumonia, 1920s and 1930s.LETTERS
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Unusual 
Manifestation of 
Toscana Virus 
Infection, Spain
To the Editor: Toscana virus 
(TOSV) causes acute meningitis and 
meningoencephalitis in Mediterra-
nean countries (1). In Spain, neurolog-
ic TOSV infection has been reported 
since 1988. All cases have been self-
limited aseptic meningitis (2). Since 
2003, we have routinely investigated 
TOSV in cerebrospinal ﬂ  uid  (CSF) 
specimens from patients with suspect-
ed viral meningitis and encephalitis 
by using cell culture and reverse tran-
scription–PCR (RT-PCR) (3,4). Also, 
as part of a regional project (05/305, 
Consejería de Salud, Junta de Anda-
lucía, Spain), we investigated TOSV 
in mild nonneurologic syndromes by 
detection of immunoglobulin (Ig) M 
against TOSV by using enzyme im-
munoassay (Diesse Diagnostica Se-
nese S.p.A, Siena, Italy). From May 
through September of 2006 and 2007, 
a total of 358 serum samples were ran-
domly selected from patients for whom 
microbiologic determinations had 
been requested to investigate febrile 
illnesses.
As a result of these virologic and 
serologic surveys, we detected 7 cases 
of TOSV infection. Mild aseptic men-
ingitis developed in 4 patients; in 3 
patients, the infection had an atypical 
manifestation, as described below.
Patient 1, a 45-year-old man, was 
referred to the Hospital Universitario 
Virgen de las Nieves in September 
2004 with confusion and a temperature 
of 39°C. He had had a splenectomy 20 
years before, and in 2002, he had re-
ceived a kidney transplant after renal 
failure resulting from meningococ-
cemia. On admission, the patient was 
receiving chronic immunosuppressive 
treatment. Ten days after admission, he 
had tonic-clonic seizures. Aphasia and 
paresis developed after an ictus of the 
left hemisphere, and his level of con-
sciousness decreased rapidly. Treat-
ment with corticosteroids was initi-
ated because vasculitis was suspected. 
The patient responded to treatment, 
and 2 months after admission, he was 
discharged. Four months later, he still 
had impaired speech and paresis. Lym-
phocytic pleocytosis, a normal glucose 
level, and elevated protein levels were 
observed in CSF samples taken during 
the 2-month period of hospitalization. 
Bacterial and fungal cultures, as well 
as results of PCR for enterovirus, her-
pes simplex virus (HSV), and varicel-
la-zoster virus (VZV), were negative 
in CSF specimens taken at admission 
and 1 month later. TOSV was detected 
by cell culture and nested RT-PCR 
in both samples (3). Anti-TOSV IgG 
was not detected in serum samples 
obtained on days 1 and 10; 5 months 
later, a borderline result was obtained. 
Anti-TOSV IgM was not detected on 
day 1 but was detected on day 10; 5 
months later, anti-TOSV IgM was 
detected. Sequence analysis of ampli-
ﬁ  ed fragments from L and S segments 
(GenBank accession nos. FJ356705 
and FJ356706, respectively) indicated 
95%–98% homology with sequences 
from Spanish TOSV strains (3) and 
84% homology with Italian reference 
strain ISS Phl.3.
Patient 2, a 54-year-old man, 
was admitted to a regional hospital in 
Granada Province in November 2007. 
He was confused and agitated, and he 
reported having fever and headache 
2 days before. On admission, he was 
receiving treatment with corticoster-
oids for Crohn disease. Analysis of the 
CSF specimen showed lymphocytic 
pleocytosis, a normal glucose level, 
and increased protein levels. Results 
of PCR for HSV, VZV, and enterovi-
rus were negative. TOSV was detected 
in the CSF sample by cell culture and 
real-time RT-PCR (4). The patient was 
treated with antimicrobial drugs and 
acyclovir. He recovered and was dis-
charged 3 weeks after admission. One 
month later, he returned with paresis 
and aphasia, secondary to an ischemic 
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Letters commenting on recent articles 
as well as letters reporting cases, out-
breaks, or original research are wel-
come. Letters commenting on articles 
should contain no more than 300 
words and 5 references; they are more 
likely to be published if submitted 
within 4 weeks of the original article’s 
publication. Letters reporting cases, 
outbreaks, or original research should 
contain no more than 800 words 
and 10 references. They may have 1 
Figure or Table and should not be di-
vided into sections. All letters should 
contain material not previously pub-
lished and include a word count.